- The pharmaceutical industry is a major contributor to market growth, as LAL testing is a crucial step in ensuring the safety and quality of drugs. In addition, the medical device industry is increasingly adopting LAL testing to meet regulatory requirements and enhance product safety
- North America dominated the LAL testing market with the largest revenue share of 42.8% in 2024, driven by stringent regulatory requirements for endotoxin testing across pharmaceutical and medical device industries
- Asia-Pacific LAL Testing market is projected to grow at the fastest CAGR of 12.6% from 2025 to 2032, driven by the rapid expansion of pharmaceutical manufacturing, particularly in countries such as China, India, and Japan
- The Gel Clot Endotoxin Test segment dominated the market with the largest market revenue share of 48.6% in 2024, owing to its widespread regulatory acceptance, cost-effectiveness, and simplicity in qualitative endotoxin detection
